New litigation is being filed against Pfizer, alleging that Depo-Provera causes an increased risk of developing meningiomas, a type of brain tumor. Depo-Provera is an injectable birth control medication that contains the hormone progestin. Studies have indicated a potential link between prolonged use of Depo-Provera and an increased risk of developing meningiomas.
Recently, a motion was filed on November 26, 2024, seeking to consolidate into a single court all of the federal lawsuits filed on behalf of women who developed brain tumors from extended Depo-Provera use.
If you or someone you know has used Depo-Provera and subsequently been diagnosed with a meningioma or other brain tumor, it’s crucial to be informed about your legal rights. Affected individuals may be entitled to compensation for medical expenses, pain and suffering, and other related damages. To explore your options, consider consulting with a qualified attorney experienced in pharmaceutical litigation. We are currently handling Depo-Provera lawsuits and can provide guidance tailored to your situation.
Data represents information on individuals’ experiences with Depo Provera, a birth control injection. Among the clients, the majority were aged 35–39 (33%), followed by 40–45 (19%) and 30–34 (17%). A significant 76% reported being diagnosed with meningioma, while 20% said they had not, and 5% were unsure. Most clients (77%) took the name-brand version of Depo Provera, while smaller groups took either the generic form (5%) or both (5%), with 14% unsure. Regarding administration, 61% of injections were given by a doctor, 37% by other medical professionals, and 2% were self-administered. In terms of total injections, 32% received 1–10, 29% had 11–20, 22% had 21–30, and 17% had over 30 injections.
Staying informed and seeking legal advice promptly can help protect your rights and ensure you receive the support you need during this challenging time.
Take Action Now – It’s Free to Join
Time is limited to file your claim. Fill out the form to the right to see if you qualify.